Abstract
Background and Aims: LDL-C is the causative agent of atherosclerosis, its levels are directly related to increased cardiovascular mortality. Lipid-lowering treatment is effective in reducing risk of new events, although the achievement of the therapeutic objectives is far from the current recommendations. In Catalonia, we do not have any registry on the management of lipids in stroke patients. To know the strategy used for the prescription of lipid-lowering treatment in patients with atherothrombotic acute ischemic stroke in hospital care in Catalonia, Spain.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
